For years, Susan Johnstone, 53, lived with an embarrassing problem that threatened to take away the activity she loved most: ...
KEYNOTE-B15 compared perioperative enfortumab vedotin plus pembrolizumab against neoadjuvant cisplatin-based chemotherapy in cisplatin-eligible MIBC, using event-free survival as the primary endpoint.
Colorblindness may be doing more than making traffic lights confusing — it could also be hiding a life-threatening warning sign. Researchers analyzing millions of medical records found that people ...
ImmunityBio’s sBLA targets BCG-unresponsive papillary NMIBC without CIS, complementing the existing U.S. approval for CIS ...
The two blockbusters have made a big difference in bladder cancer survival, but will their chemistry hold up when tested in other types?
The congenital condition spina bifida is often treated surgically in the womb, but many children still go on to have mobility issues. The addition of a patch made up of stem cells from donated placent ...
Medtech companies are increasingly investing in neuromodulation to treat UUI, which is estimated to impact 20% of adults ...
GLEN DALE, W.Va. (WTRF) — WVU Medicine Reynolds Memorial Hospital recently completed its first implant of the Altaviva device, developed by Medtronic, a new treatment option to manage bladder control ...
A York, Maine, driving instructor has pleaded not guilty to assault and disorderly conduct charges. His attorney claims the incident was a bladder-control accident related to a medical condition, not ...
Researchers at EPFL, Heidelberg University and Roche have built a human mini-bladder to show how urine composition weakens bladder tissue, helping infections recur even after antibiotics. The work was ...
Animated Z-stack showing a volume of a differentiated mini-bladder stained with phalloidin (orange) and DAPI (cyan). Credit: Paduthol et al ...
Detailed price information for Theralase Technologies Inc (TLT-X) from The Globe and Mail including charting and trades.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results